Elders Real Estate has championed breast cancer awareness for the second year running, raising $1400 over one breakfast.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
Despite the sweltering heat last Friday, morning commuters on their way to work stopped by to support the cause.
The First Street office front was decorated with bright pink for the occasion.
And the real estate office staff switched up their usual red attire for the international symbol of breast cancer awareness, pink.
"Cancer impacts all of us, and it is a cause close to our staff," owner of the real estate agent Alison Ross said.
"One of our staff proposed the idea in a meeting last year, and we were all keen to get involved."
In line with breast cancer awareness month, held across Australia in October, the team switches from selling houses to selling coffee, homemade cakes and breakfast sandwiches in a bid to raise funds for the The National Breast Cancer Foundation.
The Pink Ribbon Breakfast is a feat many across Australia take on each year to make a difference.
In 2019 the foundation has an ambitious aim to raise $1.5 million to fund research into prevention, detection and treatment of breast cancer to save thousands of lives.
Breast cancer is the most common cancer among Australian women apart from non-melanoma skin cancer.
This year, it is estimated more than 19,300 Australian women will be diagnosed with breast cancer, and more than 3,000 women are expected to die from the disease.
The Federal Government says it is committed to reducing cancer's toll on Australians, and is introducing some cost cutting measures in an attempt to save lives.
From November 1 of this year, Medicare will subsidise costly breast cancer scans, saving women up to $1,500 per scan.
The government says PET scans for advanced breast cancer will also be subsidised, saving up to $1000 per scan.
"We have also increased our commitment to McGrath Foundation breast cancer nurses. An additional $27.7 million will see the number of Commonwealth-funded nurses rise from 57 to 98 by 2022-23," a government spokesperson said.
"We continue to list the latest proven treatments for breast cancer on the PBS. In May, Ibrance® (palbociclib) was listed for patients with inoperable or metastatic hormone receptor positive breast cancer.
"Around 3,000 women each year will benefit from this decision. Without the PBS subsidy, Ibrance would cost around $55,000 for a year's treatment."
While you're with us, you can now receive updates straight to your inbox each Friday at 6am from the Katherine Times. To make sure you're up to date with all the news, sign up here.